CLINICAL_TRIALS
trial_result
· 2017-11-09
Clinical Trial Update: Effects of the TNF-alpha Inhibiton on Hemodynamic Parameters in Resistant Hypertension [Phase 4]
Summary
This update reports on the effects of TNF-alpha inhibition on hemodynamic parameters in patients with resistant hypertension in Phase 4.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Campinas, Brazil | Conditions: Hypertension | Phase 4 | Status: COMPLETED